Patty Eisenhaur
Investor Relations Contact chez MOMENTA PHARMACEUTICALS, INC.
Postes actifs de Patty Eisenhaur
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
| EVC Group, Inc. | Corporate Officer/Principal | - | - |
Historique de carrière de Patty Eisenhaur
Anciens postes connus de Patty Eisenhaur
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Investor Relations Contact | 01/08/2014 | 01/06/2018 |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
| EVC Group, Inc. |
- Bourse
- Insiders
- Patty Eisenhaur
- Expérience